The following links direct to pages listing some publications in which the Peira TM900 is used for tumor volume monitoring of mouse xenografts. These research organisations are using the instrument in their studies.

Link to work by:

Memorial Sloan Kettering Cancer Center

Link to work by:

Hainan Medical College

Work by:

Mendel University in Brno, Czech Republic

Prostate-Specifc Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Infuences In Vivo Side Efects of Doxorubicin

Departments of Genetics, Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Evidence supporting the oncogenic role of BAZ1B in colorectal cancer

International Institute of Molecular and Cell Biology, Warsaw, Poland

Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer

Poznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, Poland

Conjugation of Diclofenac with Novel Oleanolic Acid Derivatives Modulate Nrf2 and NF-κB Activity in Hepatic Cancer Cells and Normal Hepatocytes Leading to Enhancement of Its Therapeutic and Chemopreventive Potential

Institute of Biomedical Engineering, University of Oxford, UK

Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device

Genomics Research Center, Academia Sinica, Taipei, Taiwan

MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis

Taichung Veterans General Hospital, Taichung, Taiwan

Aspirin Induced Glioma Apoptosis through Noxa Upregulation

Anti-Cancer Effects of Zotarolimus Combined with 5-Fluorouracil Treatment in HCT-116 Colorectal Cancer-Bearing BALB/c Nude Mice

Chang Gung University , Department of Medicine, College of Medicine, Taiwan

The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice!

College of Medicine, Yonsei University, Seoul, Korea

SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models